. 2022 May 30;10(2):35468. doi: 10.52965/001c.35468

Table 1. Clinical characteristics of the study sample.

Variables	TG (n = 12)	CG (n = 13)	p-value
Age, mean years (SD)	45 (12.31)	41 (6.83)	0.30^a
Start anxiety crisis, n (%)
Adolescense	4 (33.30)	9 (69.20)	0.07^b
Adulthood	8 (66.70)	4 (30.80)	0.07^b
Tobacco, n (%)
Yes	4 (33.30)	8 (61.50)	0.16^b
No	8 (66.70)	5 (38.50)	0.16^b
Alcohol, n (%)
Never	1 (8.30)	3 (23.10)	0.18^b
Almost never	11 (91.70)	7 (72.00)
Sometimes	0 (0.00)	1 (7.70)
Almost always	0 (0.00)	2 (15.40)
Physical exercise, n (%)
Never	6 (50.00)	4 (30.80)	0.50^b
Almost never	0 (0.00)	1 (7.70)
Sometimes	2 (16.70)	2 (15.40)
Almost asways	3 (25.00)	2 (15.40)
Always	1 (8.30)	4 (30.80)
Insomnia, n (%)
Yes	5 (41.70)	6 (46.20)	0.82^b
No	7 (58.30)	7 (53.80)	0.82^b
CID, n (%)
Yes	11 (91.70)	9 (69.20)	0.16^b
No	1 (8.30)	4 (30.80)	0.16^b
Psychotropic drugs, n (%)
Bz	3 (25.00)	2 (15.40)	0.67^b
AD	1 (8.30)	1 (7.70)
Bz y AD	6 (50.00)	5 (38.50)
No psychotropic drug	2 (16.70)	5 (38.50)
Menstrual cycle, n (%)
Si	8 (66.70)	12 (92.30)	0.11^b
No	4 (33.30)	1 (7.70)	0.11^b
PSS (mean ± SD)	33.42 ± 6.51	34.69 ± 7.46	0.46^a
STAI-State (mean ± SD)	33.50 ± 8.45	33.46 ± 11.03	0.95^a
STAI-Trait (mean ± SD)	39.50 ± 6.58	39.46 ± 8.66	0.82^a
BDI-II (mean ± SD)	25.83 ± 11.04	27.62 ± 11.03	0.70^a
GSRS (mean ± SD)	43.33 ± 9.35	41.38 ± 13.17	0.60^a
SF36-BP (mean ± SD)	37.81 ± 7.65	39.51 ± 7.79	0.68a
SF36-PSC (mean ± SD)	45.58 ± 8.20	50.65 ± 8.11	0.10^a
SF36-MSC (mean ± SD)	32.03 ± 5.32	30.05 ± 9.95	0.43^a

Note. ^aMann-Whitney U test for independent samples; ^bChi-cuadrado test. (CID) Chronic inflammatory disease; (PSS) Perceived Stress Scale; (STAI) State-Trait Anxiety Inventory; (BDI-II) Beck Depression Inventory; (GSRS) Gastrointestinal Symptom Rating Scale; (SF-36) Short Form 36 Health Survey (BP) Body pain, (PSC) Physical Summation Component y (MSC) Mental Summation Component. (Bz) Benzodiazepines; (AD) Antidepressants.